Program
Cetylpyridinium
Also written as “Cetylpyridinium chloride”, “Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash” and “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash”.
Its studies are mostly in Gingivitis · Dental Plaque · Pharyngitis · Diabetes Mellitus, Type 2 · Onychomycosis, led by 7 companies.
Drug pageCetylpyridinium: every studyMany companies study it; this page follows only the 15 they lead. All 27 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Colgate Palmoliveits history only | 61 open or running | phase 4since Feb 6, 2015 | Jul 15, 2014 | Jan 2, 2028phase 4 · NCT07619729 |
| Procter and Gambleits history only | 20 open or running | phase 4since Sep 29, 2025 | Feb 28, 2012 | none ahead |
| Sanofiits history only | 20 open or running | phase 3since May 27, 2008 | May 27, 2008 | none ahead |
| Valenta Pharm JSCits history only | 22 open or running | phase 1since Feb 17, 2025 | Feb 17, 2025 | Dec 1, 2026phase 1 · NCT06859281 |
| Angelini Pharmaits history only | 10 open or running | phase 1since Apr 27, 2018 | Apr 27, 2018 | none ahead |
| NanoBioits history only | 10 open or running | phase 2since Mar 26, 2007 | Mar 26, 2007 | none ahead |
| Suzhou Neologics Bioscienceits history only | 11 open or running | phase 1since May 25, 2023 | May 25, 2023 | none ahead |
Also a collaborator on its studies: Cross Research.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 26, 2007First study: phase 2 study in OnychomycosisNew to NanoBioNanoBio · NCT00453271 · 443 enrolled · United States, Canada
- May 27, 2008Sanofi’s first study: phase 3 study in HealthyNew to SanofiSanofi · NCT00687037 · 30 enrolled · Brazil
- Aug 4, 2008Phase 3 study in HygieneSanofi · NCT00729599 · 31 enrolled · Brazil
- Feb 28, 2012Procter and Gamble’s first study: no phase study in GingivitisNew to Procter and GambleProcter and Gamble · NCT01549587 · 746 enrolled · United States
- Jul 15, 2014Colgate Palmolive’s first study: phase 3 study in Dental PlaqueNew to Colgate PalmoliveColgate Palmolive · NCT02193165 · 120 enrolled · Puerto Rico
- Feb 6, 20152 phase 4 studies in Dental PlaqueColgate Palmolive · NCT02366689, NCT02360995
- Apr 27, 2018Angelini Pharma’s first study: phase 1 study in HealthyNew to Angelini PharmaAngelini Pharma · NCT03706781 · 26 enrolled · Switzerland
- May 25, 2023Suzhou Neologics Bioscience’s first study: phase 1 study in Advanced Solid TumorNew to Suzhou Neologics BioscienceSuzhou Neologics Bioscience · NCT05924906 · 30 planned
- Jan 7, 2025Phase 3 study in GingivitisColgate Palmolive · NCT06770114 · 80 enrolled · Italy
- Feb 17, 2025Valenta Pharm JSC’s first studies: 2 phase 1 studies in PharyngitisNew to Valenta Pharm JSCValenta Pharm JSC · NCT06859281, NCT06857890
- Sep 29, 2025Phase 4 study in GingivitisProcter and Gamble · NCT07211061 · 69 enrolled · United States
- Nov 24, 2025Phase 3 study in GingivitisColgate Palmolive · NCT07263698 · 80 enrolled · Italy
- May 26, 2026Phase 4 study in Diabetes Mellitus, Type 2Colgate Palmolive · NCT07619729 · 10,000 planned · United States
Ahead
- Dec 1, 2026Primary completion: phase 1 study in PharyngitisValenta Pharm JSC · NCT06859281
- Dec 1, 2026Primary completion: phase 1 study in PharyngitisValenta Pharm JSC · NCT06857890
- Jan 2, 2028Primary completion: phase 4 study in Diabetes Mellitus, Type 2Colgate Palmolive · NCT07619729
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 15 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07619729Diabetes Mellitus, Type 2 · United States | 4 | By invitation | Colgate Palmolive | Jan 2, 2028 | 10,000 |
| NCT07263698Gingivitis · Italy | 3 | Completed | Colgate Palmolive | Feb 27, 2026 | 80 |
| NCT07211061Gingivitis · United States | 4 | Completed | Procter and Gamble | Nov 10, 2011 | 69 |
| NCT06859281Pharyngitis · Russia | 1 | Recruiting | Valenta Pharm JSC | Dec 1, 2026 | 24 |
| NCT06857890Pharyngitis · Russia | 1 | Recruiting | Valenta Pharm JSC | Dec 1, 2026 | 24 |
| NCT06770114Gingivitis · Italy | 3 | Completed | Colgate Palmolive | May 9, 2022 | 80 |
| NCT05924906Advanced Solid Tumor | 1 | Not yet recruiting | Suzhou Neologics Bioscience | Apr 2026 | 30 |
| NCT03706781Healthy · Switzerland | 1 | Completed | Angelini Pharma | Dec 18, 2017 | 26 |
| NCT02366689Dental Plaque · United States | 4 | Completed | Colgate Palmolive | Dec 2014 | 179 |
| NCT02360995Dental Plaque · United States | 4 | Completed | Colgate Palmolive | Aug 2014 | 129 |
| NCT02193165Dental Plaque · Puerto Rico | 3 | Completed | Colgate Palmolive | Aug 2014 | 120 |
| NCT01549587Gingivitis · United States | – | Completed | Procter and Gamble | Feb 2014 | 746 |
| NCT00729599Hygiene · Brazil | 3 | Completed | Sanofi | Aug 2008 | 31 |
| NCT00687037Healthy · Brazil | 3 | Completed | Sanofi | Feb 2008 | 30 |
| NCT00453271Onychomycosis · United States, Canada | 2 | Completed | NanoBio | Oct 2008 | 443 |
How it is read
Names in the registry
- “Cetylpyridinium chloride”, 2 entries
- “Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash”, 1 entry
- “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash”, 1 entry
- “Cetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash”, 1 entry
- “Cetylpyridinium Chloride (CPC)”, 1 entry
Conditions, from the studies’ own filings
- Gingivitis, 4 studies
- Dental Plaque, 3 studies
- Pharyngitis, 2 studies
- Diabetes Mellitus, Type 2, 1 study
- Onychomycosis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.